Provided by Tiger Trade Technology Pte. Ltd.

Eledon Pharmaceuticals, Inc.

2.78
0.0000
Post-market: 2.820.0400+1.44%19:30 EDT
Volume:638.40K
Turnover:1.77M
Market Cap:225.91M
PE:-2.82
High:2.86
Open:2.82
Low:2.75
Close:2.78
52wk High:4.60
52wk Low:1.35
Shares:81.26M
Float Shares:74.57M
Volume Ratio:0.67
T/O Rate:0.86%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9867
EPS(LYR):-0.5566
ROE:-110.71%
ROA:-39.02%
PB:3.14
PE(LYR):-4.99

Loading ...

Aug 14, 2025

Major Issues Report

Form 8-K - Current report
Aug 06, 2025

Major Issues Report

Form 8-K - Current report
Jun 12, 2025

Major Issues Report

Form 8-K - Current report
May 15, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 15, 2025

Major Issues Report

Form 8-K - Current report
Apr 14, 2025

Major Issues Report

Form 8-K/A - Current report: [Amend]
Apr 07, 2025

Major Issues Report

Form 8-K - Current report
Mar 20, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 20, 2025

Major Issues Report

Form 8-K - Current report
Dec 20, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 05, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 05, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 31, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Oct 31, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Oct 30, 2024

Major Issues Report

Form 8-K - Current report
Oct 29, 2024

Major Issues Report

Form 8-K - Current report
Oct 02, 2024

Major Issues Report

Form 8-K - Current report